An Examination of How People Who Use Drugs Conceptualize the Benefits and Drawbacks of Using Overdose Prevention Centers.  Frank D, Bennett AS, Elliott L, Scheidell JD, Walters SM, Cleland CM.  Contemp Drug Probl. 2025 Dec;52(4):584-597…

Integrating Drug Checking Services Into Substance Use Treatment—A Call to Action.  Messmer S, Kaufmann M, Peress D.  JAMA Netw Open. 2026;9(2):e2555775. doi:10.1001/jamanetworkopen.2025.55775 https://jamanetwork.com/journals/jamanetwork…

Podcast for Q & A Naloxone FDA – Food and Drug Administration, USA, aufgerufen am 01.02.2026 https://www.fda.gov/media/170061/download

Navigating pregnancy and addiction recovery: Patient perspectives on perinatal care interventions for women with opioid use disorder in Kentucky, USA.  Surratt HL, Davis OA, Nelson EO, Durr H, Fawcett K, Joy J, Schanbacher BL, Vice M, Bauer JA…

Getting de Pointes Across: Isoproterenol for Refractory Methadone-Associated Torsades de Pointes in Alcohol Withdrawal.  Wrona J, Coca C, Dietrich T, Holcomb K.  Cureus. 2026 Jan 5;18(1):e100838. doi: 10.7759/cureus.100838. PMID: 4164657…

Buprenorphine Use and the Risk of Dental Adverse Events in Patients With Opioid Use Disorder.  Okeke CM, Okonkwo M, Olateju O, Saponjac VT, Hu M, Singh R, Mursalin M, Thornton JD.  Subst Use. 2026 Jan 28;20:29768357251411168. doi: 10.117…